Tao Fu has sold stock and made no open-market buys since Apr 2017

Tao Fu is an individual corporate executive with deep experience in biopharmaceutical strategy, business development, and operations. He is currently Chief Executive Officer, Founder, and President of Attovia Therapeutics, and also serves as a venture partner at Frazier Life Sciences and a board member at Ablaze Pharmaceuticals; before that, he held senior leadership roles at Zai Lab, Portola Pharmaceuticals, and Bristol Myers Squibb.(

At Zai Lab Ltd. (NASDAQ: ZLAB), Fu joined as President and Chief Operating Officer in September 2018 and later served as Chief Strategy Officer from May 2021 to April 2022.( Zai Lab disclosed that he had been a director since 2017 and that his responsibilities included strategy, business development, CMC, quality, and other corporate functions.( Fu earned an MBA in finance and marketing from Vanderbilt University, an M.S. in biology from the University of Rochester, and completed undergraduate studies in biology at Tsinghua University; Zai Lab also reported that he holds the CFA designation.(

Written by Perplexity from public sources.